Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)

• Status: Completed
• Trial end date: 1969-12-31

Summary

The purpose of this study is to characterize the progression of disease using volumetric MRI techniques and cognitive outcome measures in patients with moderate dementia of the Alzheimer's type treated with open-label memantine.

• Phase: Phase 4

Details

• Lead Sponsor: Forest Laboratories
• Treatments: Memantine